Wockhardt Limited
Wockhardt Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: WOCKPHARMA and BSE: 532300 (ISIN INE049B01025).
It has a market capitalisation of ₹30,882 crore, a last close of ₹1,906 on 2026-10-19, a one-year return of 42.0%.
Valuation: a price-to-earnings ratio of 75.51x, a price-to-book ratio of 6.25x, a dividend yield of 0.0%.
Profitability: return on equity of 4.6%, return on capital employed of 6.9%, an operating margin of 21.7%.
Growth: sales growth of 8.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.43x, promoter holding of 49.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 30,882 |
| Last close | ₹1,906 |
| P/E (TTM) | 75.51x |
| P/B | 6.25x |
| Dividend yield | 0.0% |
| ROE (FY) | 4.6% |
| ROCE (FY) | 6.9% |
| Operating margin (TTM) | 21.7% |
| Sales growth, 3-year CAGR | 8.4% |
| Debt / equity | 0.43x |
| Promoter holding | 49.3% |
| 1-year return | 42.0% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means